Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease

British Journal of Dermatology

Volumn 153, Issue 1, 2005, Pages 59-65

  Di Renzo, M ^a   Rubegni, P ^a   Pasqui, A L ^a   Pompella, G ^a   De Aloe, G ^a   Sbano, P ^a   Cuccia, A ^a   Castagnini, C ^a   Auteri, A ^a   Pasini, F Laghi ^a   Fimiani, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Chronic graft versus host disease; Cytokine; Extracorporeal photopheresis; Monocyte

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 10; INTERLEUKIN 12; METHYLPREDNISOLONE; TACROLIMUS;

ADULT; APOPTOSIS; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PUVA; TREATMENT OUTCOME;

ADULT; APOPTOSIS; CELLS, CULTURED; CHRONIC DISEASE; COCULTURE TECHNIQUES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LYMPHOCYTES; MALE; MONOCYTES; PHOTOPHERESIS;

EID: 22944464418     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06482.x     Document Type: Article

References (29)

1. Klingebiel T, Schlegel PG. GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant 1998; 21:S45-9.
2. Ratanatharathorn V, Ayash L, Lazarus HM et al. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001; 28:121-9.
3. Lazarus HM, Rowe JM. New and experimental therapies for treating graft-versus-host disease. Blood Rev 1995; 9:117-33.
4. Edelson RL, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987; 316:297-303.
5. Russell-Jones R. Extracorporeal photopheresis in chronic cutaneous graft-versus-host disease. Bone Marrow Transplant 1998; 22:612-3.
6. Child FJ, Ratnavel R, Watchins P. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. Bone Marrow Transplant 1999; 23:881-7.
7. Bladon J, Taylor PC. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes. Br J Haematol 2002; 146:59-68.
8. Di Renzo M, Rubegni P, Sbano P et al. ECP-treated lymphocytes of chronic graft-versus host disease patients undergo apoptosis which involves both the Fas/FasL system and the bcl-2 protein family. Arch Dermatol Res 2003; 295:175-82.
9. Tambur AR, Ortegel JW, Morales A et al. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc 2000; 32:747-8.
10. Vowels BR, Cassin M, Boufal MH et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-α by monocytes: implication for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992; 98:686-92.
11. Voll RE. Immunosuppressive effects of apoptotic cells. Nature 1997; 390:350-1.
12. Seaton ED, Szydlo RM, Kanfer E et al. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003; 102:1217-23.
13. Lund PK, Namork E, Henning Brorson S et al. The fate of monocytes during 24 h of culture as revealed by flow cytometry and electron microscopy. J Immunol Methods 2002; 270:63-76.
14. Tokura Y, Seo N, Tomida M et al. Augmentation of monocyte interleukin-8 production by psoralen/UVA treated CD4+ T cells. Exp Dermatol 2002; 11:564-72.
15. Tokura Y, Seo N, Yagi H, Takigawa M. Photoactivational cytokine-modulatory action of 8-methoxypsoralen plus ultraviolet A in lymphocytes, monocytes and cutaneous T cell lymphoma cells. Ann NY Acad Sci 2001; 941:185-93.
16. Klosner G, Trautinger F, Knobler R, Neuner P. Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response. J Invest Dermatol 2001; 116:459-62.
17. Lauwerys BR, Renauld JC, Houssiau FA. Inhibition of in vitro immunoglobulin production by IL-12 in murine chronic graft-vs-host disease: synergism with IL-18. Eur J Immunol 1998; 28:2017-24.
18. Okubo T, Hagiwara E, Ohno S et al. Administration of an IL-12-encoding DNA plasmid prevents the development of chronic graft-versus-host disease (GVHD). J Immunol 1999; 162:4013-7.
19. Adorini L. Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases. Cell Mol Life Sci 1999; 55:1610-25.
20. Rook AH, Kuzel TM, Olsen EA. Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin 12 and interleukin 2. Hematol Oncol Clin North Am 2003; 17:1435-48.
21. Di Renzo M, Rubegni P, De Aloe G et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology 1997; 92:99-103.
22. Tanaka J, Imamura M, Kasai M et al. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease. Bone Marrow Transplant 1997; 19:571-6.
23. Gorgun G, Miller KB, Foss F. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002; 100:941-7.
24. Craciun LI, Stordeur P, Schandené L et al. Increased production of interleukin 10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation 2002; 7:995-1000.
25. Girardi M, Schechner J, Glusac E et al. Transimmunization and the evolution of photochemotherapy. Transfus Apheresis Sci 2002; 26:181-90.
26. Sun EW, Shi YF. Apoptosis: the quiet death silences the immune system. Pharmacol Ther 2001; 92:135-45.
27. Fadok VA, Bratton DL, Konowal A et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2 and PAF. J Clin Invest 1998; 101:890-8.
28. Byrne A, Reen DJ. Lipopolysaccaride induces rapid production of IL10 by monocytes in the presence of apoptotic neutrophils. J Immunol 2002; 168:1968-77.
29. Lin MT, Storer B, Martin PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host-disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349:2201-10.